These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 36008925)

  • 21. Acceptability of point-of-care viral load testing to facilitate differentiated care: a qualitative assessment of people living with HIV and nurses in South Africa.
    Msimango L; Gibbs A; Shozi H; Ngobese H; Humphries H; Drain PK; Garrett N; Dorward J
    BMC Health Serv Res; 2020 Nov; 20(1):1081. PubMed ID: 33239012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differentiated service delivery models among PLHIV in Akwa Ibom and Cross River States, Nigeria during the COVID-19 pandemic: descriptive analysis of programmatic data.
    Sanwo O; Persaud NE; Nwaokoro P; Idemudia A; Akpan U; Toyo O; Imohi P; Badru T; Obiora-Okafo C; Uzochukwu CE; Aliu O; Olatunbosun K; Pandey SR; Khamofu H; Chiegil R; James E; Iyortim I; Oqua D; Bateganya M
    J Int AIDS Soc; 2021 Oct; 24 Suppl 6(Suppl 6):e25820. PubMed ID: 34713591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acceptability of lifelong treatment among HIV-positive pregnant and breastfeeding women (Option B+) in selected health facilities in Zimbabwe: a qualitative study.
    Chadambuka A; Katirayi L; Muchedzi A; Tumbare E; Musarandega R; Mahomva AI; Woelk G
    BMC Public Health; 2017 Jul; 18(1):57. PubMed ID: 28743251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient preferences for HIV service delivery models; a Discrete Choice Experiment in Kisumu, Kenya.
    Mando RO; Moghadassi M; Juma E; Ogollah C; Packel L; Kulzer JL; Kadima J; Odhiambo F; Eshun-Wilson I; Kim HY; Cohen CR; Bukusi EA; Geng E
    PLOS Glob Public Health; 2022; 2(10):e0000614. PubMed ID: 36962597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Similar costs and outcomes for differentiated service delivery models for HIV treatment in Uganda.
    Guthrie T; Muheki C; Rosen S; Kanoowe S; Lagony S; Greener R; Miot J; Balidawa H; Kiggundu J; Calnan J; Dejene S; Xulu T; Sigwebela N; Long LC
    BMC Health Serv Res; 2022 Nov; 22(1):1315. PubMed ID: 36329450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patient costs for prevention of mother-to-child HIV transmission and antiretroviral therapy services in public health facilities in Zimbabwe.
    Chingombe I; Mapingure MP; Balachandra S; Chipango TN; Gambanga F; Mushavi A; Apollo T; Suraratdecha C; Rogers JH; Ruangtragool L; Gonese E; Musuka GN; Mugurungi OM; Harris TG
    PLoS One; 2021; 16(8):e0256291. PubMed ID: 34407129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. People living with HIV's perspectives of acceptability of fee for home delivery of ART: a qualitative study.
    Ntinga X; Musiello F; Pita T; Mabaso N; Celum C; Szpiro A; van Rooyen H; Barnabas R; van Heerden A
    BMC Health Serv Res; 2024 Jan; 24(1):88. PubMed ID: 38233824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perceptions and factors associated with the uptake of the community client-led antiretroviral therapy delivery model (CCLAD) at a large urban clinic in Uganda: a mixed methods study.
    Walusaga HAG; Atuyambe LM; Muddu M; Mpirirwe R; Nangendo J; Kalibbala D; Semitala FC; Katahoire AR
    BMC Health Serv Res; 2023 Oct; 23(1):1165. PubMed ID: 37885014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient and health worker experiences of differentiated models of care for stable HIV patients in Malawi: A qualitative study.
    Prust ML; Banda CK; Callahan K; Nyirenda R; Chimbwandira F; Kalua T; Eliya M; Ehrenkranz P; Prescott M; McCarthy E; Tagar E; Gunda A
    PLoS One; 2018; 13(7):e0196498. PubMed ID: 30024874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implementing six multi-month dispensing of antiretroviral therapy in Ethiopia: perspectives of clients and healthcare workers.
    Mantell JE; Zech JM; Masvawure TB; Assefa T; Molla M; Block L; Duguma D; Yirsaw Z; Rabkin M
    BMC Health Serv Res; 2023 May; 23(1):563. PubMed ID: 37259098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Satisfaction with service delivery among HIV treatment clients enrolled in differentiated and conventional models of care in South Africa: a baseline survey.
    Mokhele I; Huber A; Rosen S; Kaiser JL; Lekodeba N; Ntjikelane V; Hendrickson C; Scott N; Pascoe S
    J Int AIDS Soc; 2024 Mar; 27(3):e26233. PubMed ID: 38528370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimizing Differentiated HIV Treatment Models in Urban Zimbabwe: Assessing Patient Preferences Using a Discrete Choice Experiment.
    Strauss M; George G; Mantell JE; Mapingure M; Masvawure TB; Lamb MR; Zech JM; Musuka G; Chingombe I; Msukwa M; Boccanera R; Gwanzura C; Apollo T; Rabkin M
    AIDS Behav; 2021 Feb; 25(2):397-413. PubMed ID: 32812124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes of Three- Versus Six-Monthly Dispensing of Antiretroviral Treatment (ART) for Stable HIV Patients in Community ART Refill Groups: A Cluster-Randomized Trial in Zimbabwe.
    Fatti G; Ngorima-Mabhena N; Mothibi E; Muzenda T; Choto R; Kasu T; Tafuma TA; Mahachi N; Takarinda KC; Apollo T; Mugurungi O; Chasela C; Hoffman RM; Grimwood A
    J Acquir Immune Defic Syndr; 2020 Jun; 84(2):162-172. PubMed ID: 32097252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Managers' and providers' perspectives on barriers and facilitators for the implementation of differentiated service delivery models for HIV treatment in Mozambique: a qualitative study.
    Moiana Uetela D; Gimbel S; Inguane C; Uetela O; Dinis A; Couto A; Gaspar I; Gudo ES; Chicumbe S; Gaveta S; Augusto O; Sherr K
    J Int AIDS Soc; 2023 Mar; 26(3):e26076. PubMed ID: 36916122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Community-based differentiated service delivery models incorporating multi-month dispensing of antiretroviral treatment for newly stable people living with HIV receiving single annual clinical visits: a pooled analysis of two cluster-randomized trials in southern Africa.
    Fatti G; Ngorima-Mabhena N; Tiam A; Tukei BB; Kasu T; Muzenda T; Maile K; Lombard C; Chasela C; Grimwood A
    J Int AIDS Soc; 2021 Oct; 24 Suppl 6(Suppl 6):e25819. PubMed ID: 34713614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient experiences and preferences for antiretroviral therapy service provision: implications for differentiated service delivery in Northwest Ethiopia.
    Belay YA; Yitayal M; Atnafu A; Taye FA
    AIDS Res Ther; 2022 Jun; 19(1):30. PubMed ID: 35761352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Competing risk of mortality on loss to follow-up outcome among patients with HIV on ART: a retrospective cohort study from the Zimbabwe national ART programme.
    Matsena Zingoni Z; Chirwa T; Todd J; Musenge E
    BMJ Open; 2020 Oct; 10(10):e036136. PubMed ID: 33028546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. "We are part of a family". Benefits and limitations of community ART groups (CAGs) in Thyolo, Malawi: a qualitative study.
    Pellecchia U; Baert S; Nundwe S; Bwanali A; Zamadenga B; Metcalf CA; Bygrave H; Daho S; Ohler L; Chibwandira B; Kanyimbo K
    J Int AIDS Soc; 2017 Mar; 20(1):21374. PubMed ID: 28406273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patient and health-care worker experiences of an HIV viral load intervention using SMS: A qualitative study.
    Venables E; Ndlovu Z; Munyaradzi D; Martínez-Pérez G; Mbofana E; Nyika P; Chidawanyika H; Garone DB; Bygrave H
    PLoS One; 2019; 14(4):e0215236. PubMed ID: 30973925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acceptability of Community-Based Tuberculosis Preventive Treatment for People Living with HIV in Zimbabwe.
    Msukwa MK; Mapingure MP; Zech JM; Masvawure TB; Mantell JE; Musuka G; Apollo T; Boccanera R; Chingombe I; Gwanzura C; Howard AA; Rabkin M
    Healthcare (Basel); 2022 Jan; 10(1):. PubMed ID: 35052280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.